unreviewed
LDL receptor (homeostatic uptake, not synthetic enzyme)
0 reactions · 0 pathways
What it does, reaction by reaction
0 reactions
This enzyme appears only in the regulation table, with no catalysed step recorded.
What accelerates and inhibits it
Regulation is pathway-specific, so each context is listed separately
1 entries
Cholesterol Biosynthesis (Mevalonate Pathway)
Accelerated by
SREBP-2 during low cellular cholesterol
Inhibited by
Intracellular cholesterol; PCSK9-mediated receptor degradation
Hormonal control
Insulin can support receptor expression; hepatic sterol status is dominant
Recent literature
No articles returned.